BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Industrials | 6% |
| 5 | Healthcare | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECHO
1876
EchoStar
ECHO
$26.6B
| $135K | ﹤0.01% |
3,424
+2,259
| +194% | +$92.5K |
|
1877
Axos Financial
AX
$5.82B
| $135K | ﹤0.01% |
5,108
+3,652
| +251% | +$86.8K |
|
|
DPLO
1878
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $135K | ﹤0.01% |
3,010
+2,643
| +720% | +$99.4K |
|
1879
Celestica
CLS
$42.2B
| $135K | ﹤0.01% |
8,843
-59,849
| -87% | -$730K |
|
|
EXAM
1880
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $134K | ﹤0.01% |
3,439
+2,613
| +316% | +$108K |
|
|
SFY
1881
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
| $134K | ﹤0.01% |
65,900
-33,511
| -34% | -$82.7K |
|
1882
Mativ Holdings
MATV
$670M
| $134K | ﹤0.01% |
3,353
+2,632
| +365% | +$112K |
|
1883
Integer Holdings
ITGR
$4.26B
| $133K | ﹤0.01% |
2,712
+2,066
| +320% | +$101K |
|
|
ALX
1884
Alexander's
ALX
$1.38B
| $132K | ﹤0.01% |
323
+186
| +136% | +$79.2K |
|
1885
Apogee Enterprises
APOG
$887M
| $132K | ﹤0.01% |
2,515
+1,822
| +263% | +$98.3K |
|
|
MRC
1886
DELISTED
MRC Global
MRC
| $132K | ﹤0.01% |
8,569
+6,317
| +281% | +$95.4K |
|
1887
Huntington Ingalls Industries
HII
$12.9B
| $132K | ﹤0.01% |
1,174
-8,645
| -88% | -$1.1M |
|
|
LOGM
1888
DELISTED
LogMein, Inc.
LOGM
| $132K | ﹤0.01% |
2,049
+1,476
| +258% | +$92.5K |
|
|
VRTU
1889
DELISTED
Virtusa Corporation
VRTU
| $132K | ﹤0.01% |
2,567
+1,955
| +319% | +$86.9K |
|
1890
Trex
TREX
$5.05B
| $132K | ﹤0.01% |
10,672
+7,460
| +232% | +$95.6K |
|
|
KYNB
1891
Kyntra Bio
KYNB
$28.6M
| $132K | ﹤0.01% |
224
+215
| +2,389% | +$125K |
|
|
MEG
1892
DELISTED
Media General, Inc
MEG
| $132K | ﹤0.01% |
7,972
+7,152
| +872% | +$119K |
|
|
NPBC
1893
DELISTED
NATL PENN BANCSHARES INC
NPBC
| $131K | ﹤0.01% |
11,656
+8,719
| +297% | +$94.5K |
|
1894
Omnicell
OMCL
$1.7B
| $131K | ﹤0.01% |
3,485
+2,619
| +302% | +$95.5K |
|
|
LNCE
1895
DELISTED
Snyders-Lance, Inc.
LNCE
| $131K | ﹤0.01% |
4,064
+2,931
| +259% | +$90.4K |
|
|
YELL
1896
DELISTED
Yellow Corporation Common Stock
YELL
| $131K | ﹤0.01% |
10,102
+9,351
| +1,245% | +$139K |
|
|
IMGN
1897
DELISTED
Immunogen Inc
IMGN
| $131K | ﹤0.01% |
9,109
+5,115
| +128% | +$56.2K |
|
|
ASRT
1898
DELISTED
Assertio
ASRT
| $131K | ﹤0.01% |
102
+79
| +343% | +$108K |
|
1899
MillerKnoll
MLKN
$1.62B
| $131K | ﹤0.01% |
4,519
+3,470
| +331% | +$98.8K |
|
1900
Protolabs
PRLB
$2.18B
| $131K | ﹤0.01% |
1,937
+1,399
| +260% | +$98.8K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.